Cafepharma Today

January 24 2020 - FDA decision coming soon on Aimmune's contested peanut allergy drug
FDA decision coming soon on Aimmune's contested peanut allergy drug
PwC sees an extremely active 2020 for dealmaking
Roche's Tecentriq fails in bladder cancer trial
Pfizer launches biosims for Roche's 'big three' cancer drugs in the US
*please scroll down for all the latest news*

Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe

Today's most popular searches:

Current News

submit a press release

Click here to stay updated on CP happenings
FDA decision nears on Aimmune's contested peanut allergy drug
BioPharma Dive
Friday, January 24, 2020 - 12:07pm
tags:
FDA, Aimmune, peanut allergy, Palforzia, DBV Technologies, Viaskin Peanut
Where Will Intercept Pharmaceuticals Be in 5 Years?
Motley Fool
Friday, January 24, 2020 - 11:06am
tags:
Intercept Pharma, Ocaliva
Hey Sanofi, you need to freshen up your pipeline, perhaps with M&A: report
Fierce Pharma
Friday, January 24, 2020 - 11:02am
tags:
Sanofi, M&A, Gilead Sciences
Edwards Lifesciences stock takes a hit on TAVR report
Mass Device
Friday, January 24, 2020 - 11:01am
tags:
devices, Edwards Lifesciences, TAVR
New Optical Biosensor Can Cut into Sepsis Diagnosis Time
Medical Devices and Diagnostics Industry
Friday, January 24, 2020 - 10:59am
tags:
devices, biosensors, sepsis, nanotechnology
PwC report sees pharma-biotech deals 'to be extremely active in 2020'
Fierce Biotech
Friday, January 24, 2020 - 10:57am
tags:
M&A, PwC
Upcoming events – Genmab's route to market, and late-stage data for Zogenix
EP Vantage
Friday, January 24, 2020 - 10:50am
tags:
Genmab, tisotumab vedotin, cervical cancer, Zogenix, Fintepla, Lennox-Gastaut Syndrome
Ipsen’s quick fix backfires
EP Vantage
Friday, January 24, 2020 - 10:48am
tags:
Ipsen, bone disease, palovarotene
Trifecta of sickle cell disease therapies extend life expectancy, but are not cost-effective — ICER
Endpoints
Friday, January 24, 2020 - 10:30am
tags:
ICER, sickle cell disease, Novartis, Adakveo, Global Blood Therapeutics, Oxbryta, Emmaus Life Sciences, Endari
Pfizer launches biosimilars to Roche’s ‘big three’ cancer drugs in US
Pharmaforum
Friday, January 24, 2020 - 10:11am
tags:
Pfizer, Roche, biosimilars, Avastin, Zirabev, Herceptin, Trazimera, Rituxan, Ruxience
Roche's Tecentriq fails trial in form of urothelial cancer
Reuters
Friday, January 24, 2020 - 10:08am
tags:
Roche, Genentech, clinical trials, Tecentriq, urothelial cancer, bladder cancer
Addition of Pegilodecakin to FOLFOX Did Not Improve OS in Metastatic Pancreatic Cancer
Cancer Therapy Advisor
Friday, January 24, 2020 - 12:05am
tags:
Eli Lilly, pegilodecakin, pancreatic cancer, clinical trials, metastatic pancreatic cancer
FDA Warns of Cyber Risks With Certain GE Devices
RAPS.org
Thursday, January 23, 2020 - 11:59pm
tags:
GE Healthcare, FDA, devices, cybersecurity
Gilead Considering Ebola Drug as Potential Coronavirus Treatment
Motley Fool
Thursday, January 23, 2020 - 11:56pm
tags:
Gilead Sciences, Wuhan Coronavirus, remdesivir
Intuitive Surgical Grows Profits by 22% in the Fourth Quarter
Motley Fool
Thursday, January 23, 2020 - 11:54pm
tags:
Intuitive Surgical, devices, earnings
Epizyme drug granted approval by FDA for rare cancer
BioPharma Dive
Thursday, January 23, 2020 - 11:52pm
tags:
Epizyme, FDA, Tazverik, Eisai, epithelioid sarcoma
23andMe Lays Off 14% Of Workforce Amid Declining DNA Test Sales
Forbes
Thursday, January 23, 2020 - 11:48pm
tags:
23andMe, layoffs, diagnostics
Insys founder John Kapoor sentenced to 5 1/2 years for orchestrating opioid scheme
Marketwatch
Thursday, January 23, 2020 - 5:01pm
tags:
INSYS Therapeutics, John Kapoor, opioids, kickbacks, opioid crisis
With Vascepa nod in the bag, Amarin rolls CV risk campaign targeting passé prescription meds
Fierce Pharma
Thursday, January 23, 2020 - 12:33pm
tags:
Amarin, Vascepa, Cardiovascular, television ads, DTC ads
BeiGene’s Tislelizumab Could Challenge Merck’s Keytruda in the Checkpoint Inhibitor Market
BioSpace
Thursday, January 23, 2020 - 12:22pm
tags:
BeiGene, tiselizumab, non-small cell lung cancer, Merck, Keytruda

Pages

Latest CP Wire Articles

Seelos Therapeutics Files Paperwork for $14 Million Offering
ADiTxT Therapeutics Files for $25 Million IPO
[release] Duke University Researcher Calls for a ‘His and Hers’ Approach to Tackling Hypertension
PPD Files the Paperwork for $100 Million IPO
Mirum Pharmaceuticals Files for $63 Million Offering
Arcutis Biotherapeutics Files for $100 Million IPO
Avadim Health Files for $50 Million IPO
PDS Biotechnology Files for $14 Million Offering
Processa Pharmaceuticals Files for $15 Million Offering
[release] ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

Latest Pharmagather Articles

Phosphorylation Without Pain
In the Pipeline
A Connected and Collaborative Healthcare Ecosystem Will Drive Innovation
pharmexec technology
Pharm Exec's Emerging Pharma Leaders 2020 Call for Nominations
pharmexec top feature
Will It Learn? Can It Learn?
In the Pipeline
Sorting it Out – FDA AdComm Review for 2019
eye on fda
New book illustrating disease pathways released
Elsevier
Interesting trends, but not many mergers, discussed at JPM2020
Elsevier
Opening the Lid on Sarepta’s Drug Approvals
In the Pipeline
Why Part D Plans Prefer High List Price Drugs That Raise Costs for Seniors
Drug Channels
Pharma Jobs from Indeed

Pharma and Device News from NASDAQ

Veloxis Pharmaceuticals A/S: Major Shareholder Notifications
Friday, January 24, 2020 - 9:22am
Savaria declares its monthly dividend
Friday, January 24, 2020 - 7:45am
Veloxis Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer
Thursday, January 23, 2020 - 1:58pm
Noblegen joins Canadian Government’s delegation at Cleantech Forum in San Francisco
Thursday, January 23, 2020 - 8:30am
Onconova Therapeutics Regains Rigosertib Rights in Greater China
Thursday, January 23, 2020 - 8:30am
Rapid Dose Therapeutics and McMaster University Awarded NSERC Research and Development Grant to Develop Oral Dissolvable Film for Enhanced Drug Delivery
Thursday, January 23, 2020 - 7:30am
Zomedica to Focus on TRUFORMA™ Commercialization
Thursday, January 23, 2020 - 6:55am
CytoDyn to Present at Wall Street Reporter’s “NEXT SUPER STOCK Live” Conference on January 23, 2020
Wednesday, January 22, 2020 - 1:16pm
Noblegen launches plant-based “whole egg” powder, “the egg.”, with their new food and ingredient brand, Eunite™
Wednesday, January 22, 2020 - 8:30am
Dermavant Appoints Chris Chapman as Chief Commercial Officer
Wednesday, January 22, 2020 - 8:00am

Want to host your own webinar?

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information